Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Sieghart

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Memo|September 18, 2018
Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?Matthias Pinter, Wolfgang Sieghart
Journal of Hepatology|February 15, 2015
Transarterial chemoembolization: modalities, indication, and patient selectionWolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic
ESMO Open|November 16, 2016
Cancer and liver cirrhosis: implications on prognosis and managementMatthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, et al.
Wiener Klinische Wochenschrift|January 18, 2011
Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case reportMatthias Pinter, Wolfgang Sieghart, Michael Reisegger, et al.
Wiener Klinische Wochenschrift|July 30, 2011
Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Epidemiological trends of hepatocellular carcinoma in AustriaMatthias Pinter, Florian Hucke, Nadine Zielonke, et al.
Arthritis and Rheumatism|May 28, 2010
Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritisDaniel Cejka, Silvia Hayer, Birgit Niederreiter, et al.
Anticancer Research|February 5, 2009
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivoDaniel Cejka, Matthias Preusser, Thorsten Fuereder, et al.
BMC Cancer|November 18, 2015
Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cellsPhilipp Wittmann, Markus Grubinger, Christian Gröger, et al.
Thrombosis and Haemostasis|February 24, 2006
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis CWolfgang Sieghart, Monika Homoncik, Bernd Jilma, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Memo|September 18, 2018
Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?Matthias Pinter, Wolfgang Sieghart
Journal of Hepatology|February 15, 2015
Transarterial chemoembolization: modalities, indication, and patient selectionWolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic
ESMO Open|November 16, 2016
Cancer and liver cirrhosis: implications on prognosis and managementMatthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, et al.
Wiener Klinische Wochenschrift|January 18, 2011
Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case reportMatthias Pinter, Wolfgang Sieghart, Michael Reisegger, et al.
Wiener Klinische Wochenschrift|July 30, 2011
Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Epidemiological trends of hepatocellular carcinoma in AustriaMatthias Pinter, Florian Hucke, Nadine Zielonke, et al.
Arthritis and Rheumatism|May 28, 2010
Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritisDaniel Cejka, Silvia Hayer, Birgit Niederreiter, et al.
Anticancer Research|February 5, 2009
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivoDaniel Cejka, Matthias Preusser, Thorsten Fuereder, et al.
BMC Cancer|November 18, 2015
Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cellsPhilipp Wittmann, Markus Grubinger, Christian Gröger, et al.
Thrombosis and Haemostasis|February 24, 2006
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis CWolfgang Sieghart, Monika Homoncik, Bernd Jilma, et al.
Pageof 7